Gene · 1601
DAB2: DAB adaptor protein 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. DAB2: DAB adaptor protein 2. Genes, record 1601. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1601
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P98082 | Disabled homolog 2 | 770 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents23
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 43939 | P98082 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 4899 | P98082 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 4474 | P98082 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 4474 | P98082 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 4899 | P98082 | Espacenet |
| EP 4484957 A1 | 2025-01-01 | 43 | P98082 | Espacenet |
| WO 2023162878 A | 2023-08-31 | 43 | P98082 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 22364 | P98082 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 125335 | P98082 | Espacenet |
| US 11015221 B2 | 2021-05-25 | 1 | P98082 | Espacenet |
1 to 10 of 23
See all 23 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,467
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | DAB2 papers | Newest fiscal year |
|---|---|---|---|
| R01CA154663 | TGFbeta-regulated epithelial-mesenchymal transition (EMT) | 9 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 7 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 5 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 5 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 4 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 4 | 2025 |
| R01DK076077 | Adaptive and maladaptive repair after kidney injury | 4 | 2025 |
| R01HL086694 | From GWAS loci to blood pressure genes, variants & mechanisms - Renewal | 4 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 4 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 3 | 2025 |
1 to 10 of 1,467Source NIH's project files
See all 1,467 nih grantsPapers1,661
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TGF-β2 promotes autophagy-mediated resistance to doxorubicin in metastatic colon cancer cells via HMGB1. | Med Oncol | 2026 | 42789212 | PubTator, text mining | PubMed |
| Proteomics in the discovery of biomarkers of major complications after allogeneic hematopoietic cell transplantation. | Curr Opin Hematol | 2026 | 42673525 | PubTator, text mining | PubMed |
| Dual-Gene Edited Extracellular Vesicles Remodel the Redox Homeostasis to Inhibit Ferroptosis in Intervertebral Disc Degeneration. | Adv Sci (Weinh) | 2026 | 42621705 | PubTator, text mining | PubMed |
| Integrative genomic and transcriptomic analysis of hypertension in a Taiwanese population. | J Hypertens | 2026 | 42517328 | PubTator, text mining | PubMed |
| Integrative transcriptomics and scpagwas analysis predicts immune-related markers of preeclampsia. | J Reprod Immunol | 2026 | 42442143 | PubTator, text mining | PubMed |
| Application of single-cell RNA sequencing in preeclampsia. | Front Glob Womens Health | 2026 | 42367612 | PubTator, text mining | PubMed |
| Beyond structure: spectroscopic imaging in cryogenic electron microscopy. | Curr Opin Struct Biol | 2026 | 42302492 | PubTator, text mining | PubMed |
| Epstein-Barr virus-encoded microRNAs: central players in nasopharyngeal and gastric carcinoma pathogenesis. | Arch Virol | 2026 | 42143203 | PubTator, text mining | PubMed |
| SFK Inhibition Suppresses EBV-Encoded BART miRNAs and Induces Apoptosis in EBV-Positive Gastric Epithelial Cells. | Cancers (Basel) | 2026 | 41976305 | PubTator, text mining | PubMed |
| Heterogeneous nuclear ribonucleoprotein K in cancer biology and its therapeutic applications (Review). | Mol Med Rep | 2026 | 41891975 | PubTator, text mining | PubMed |
1 to 10 of 1,661
See all 1,661 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1601
GET https://conductscience.org/api/genes/v1/1601/patents?page=2